Abstract:Background Current guidelines support primary percutaneous coronary intervention (primary PCI) as the first treatment of choice (as opposed to thrombolytic therapy) for patients with acute ST-segment elevation myocardial infarction (STEMI) especially when delivered within 12 hours of symptom onset. We aimed to evaluate the impact of different clinical pathways on reduction of reperfusion delay and subsequent improvement in outcomes in patients with STEMI.Methods From November 2005 to November 2007, 546 consecutive patients with definite STEMI, who upon arrival at the emergency room were triaged to undergo primary PCI, were included. Of them, 271 patients were brought directly to catheterization laboratory (rapid group), and 275 patients were admitted to the coronary care unit (CCU) or cardiac ward first, and then transferred to the catheterization laboratory (non-rapid group). Primary endpoint was door-to-balloon (D2B) time, and secondary endpoints included infarct size assessed by peak CK-MB level and rates of major cardiac adverse events (MACE) including death, reinfarction, or target-vessel revascularization during hospitalization and at 30-day clinical follow-up.Results Baseline clinical characteristics, angiographic features and procedural success rates were comparable between the two groups, except that more patients received glycoprotein IIb/IIIa receptor inhibitors before angiography (84.0% and 77.1, P=0.042) and had TIMI 3 flow in the culprit vessel at initial angiogram (17.1 % and 9.2%, P=0.007) in the non-rapid group. The D2B time was shortened ((108 +/- 44) minutes and (138 +/- 31) minutes, P <0.0001), and number of patients with D2B time <90 minutes was greater (22.6% and 10.9%, P <0.0001) in the rapid group. The advantages associated with rapid intra-hospital transfer were enhanced if the patients presented to the hospital at regular hours. Peak CK-MB level was significantly reduced in the rapid group. In-hospital mortality (4.1% and 5.8%) and cumulative MACE rate (7.0% and 9.8%) did not significantly differ between rapid and non-rapid groups. At 30 days, cumulative death- and MACE-free survival rates were improved in the rapid group (94.5% and 89.5%, P=0.035; 90.1% and 84.0%, P=0.034, respectively).Conclusions Clinical pathway with bypass of CCU/cardiac ward admission was associated with rapid reperfusion, smaller infarct size, and improved short-term survival for patients with STEMI undergoing primary PCI. In the future, it is essential to reduce the time delay for patients presenting at off-hours.

Clinical benefits of primary percutaneous coronary intervention for ST-elevation myocardial infarction patients with initial TIMI grade 3 flow in infarction-related artery

Role of ST‐Segment Resolution Alone and in Combination with TIMI Flow after Primary Percutaneous Coronary Intervention for ST‐Segment–Elevation Myocardial Infarction

Long-Term Effects of Drug-Eluting Stents Versus Bare Metal Stents on Patients with Acute St-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Outcomes of 3-Year Clinical Follow-Up

Long-term Outcome Analysis of Patients Underwent Percutaneous Coronary Intervention with Prior Ischemic Stroke

Treatment delay and reperfusion management of acute ST-segment elevation myocardial infarction: analysis of the China STEMI Care Project Phase 1

Complete Revascularization Versus Culprit-Only Revascularization in ST-segment Elevation Myocardial Infarction and Multivessel Disease Patients Undergoing Primary Percutaneous Coronary Intervention: A Meta-Analysis and Trial Sequential Analysis

Early routine post-thrombolysis percutaneous coronary intervention vs. primary PCI in ST-segment elevated myocardial infarction: a comparative study

Comparative Effects Of Percutaneous Coronary Intervention For Infarct-Related Artery Only Or For Both Infarct- And Non-Infarct-Related Arteries In Patients With St-Elevation Myocardial Infarction And Multi-Vessel Disease

The role of late reperfusion in ST-segment elevation myocardial infarction: a real-world retrospective cohort study

Influence of percutaneous coronary intervention timing on the prognosis of patients with acute ST segment elevation myocardial infarction

Comparison of the clinical efficacy of primary percutaneous coronary intervention with thrombolytic therapy for acute myocardial infarction

Effect of different stent implantation time for percutaneous coronary intervention on efficacy and prognosis of acute ST-segment elevation myocardial infarction

Impact of Different Clinical Pathways on Outcomes of Patients with Acute St-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: the Rapid-Ami Study

Microvascular reperfusion of fibrinolysis followed by percutaneous coronary intervention versus primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction

Effect of Time-to-reperfusion on Myocardial Reperfusion after Primary Coronary Intervention for Acute Myocardial Infarction

Impact of different strategies of complete percutaneous revascularization on prognosis of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease

Remote Ischaemic Preconditioning Reduces Myocardial Ischaemic Reperfusion Injury in Patients with St-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Outcomes of Primary Percutaneous Coronary Intervention for Acute ST-elevation Myocardial Infarction in Patients Aged over 75 Years.

Safety and short-term outcome of multivessel percutanous coronary revascularization after acute myocardial infarction

Impact of Angina Prior to Acute ST-elevation Myocardial Infarction on Short-Term Outcomes after Primary Percutaneous Coronary Intervention: Results from the Shanghai Registry of Acute Coronary Syndrome (SRACE).

Reperfusion Strategy of ST-Elevation Myocardial Infarction: A Meta-Analysis of Primary Percutaneous Coronary Intervention and Pharmaco-Invasive Therapy